Javier Garjón

593 total citations
40 papers, 365 citations indexed

About

Javier Garjón is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Javier Garjón has authored 40 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 7 papers in Epidemiology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Javier Garjón's work include Blood Pressure and Hypertension Studies (8 papers), Pharmaceutical Practices and Patient Outcomes (6 papers) and Pharmaceutical studies and practices (6 papers). Javier Garjón is often cited by papers focused on Blood Pressure and Hypertension Studies (8 papers), Pharmaceutical Practices and Patient Outcomes (6 papers) and Pharmaceutical studies and practices (6 papers). Javier Garjón collaborates with scholars based in Spain, United States and Venezuela. Javier Garjón's co-authors include Luis Carlos Saiz, Juan Erviti, Javier Gorricho, Leire Leache, Antonio López‐Rueda, Álvaro Alonso, Idoia Gaminde, Julián Librero, Berta Ibáñez and José-Ramón Rueda and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cochrane Database of Systematic Reviews and British Journal of Clinical Pharmacology.

In The Last Decade

Javier Garjón

35 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javier Garjón Spain 11 128 60 55 41 34 40 365
Luis Carlos Saiz Spain 12 124 1.0× 48 0.8× 56 1.0× 41 1.0× 38 1.1× 40 386
Seyed Mehrdad Hamrahian United States 8 155 1.2× 28 0.5× 41 0.7× 35 0.9× 24 0.7× 11 346
Engi Algharably Germany 11 109 0.9× 51 0.8× 25 0.5× 25 0.6× 36 1.1× 26 546
Xindong Qin China 8 63 0.5× 66 1.1× 36 0.7× 61 1.5× 45 1.3× 18 371
Eric Dietrich United States 13 208 1.6× 30 0.5× 54 1.0× 36 0.9× 33 1.0× 45 467
David K Cundiff United States 11 183 1.4× 39 0.7× 49 0.9× 86 2.1× 25 0.7× 27 467
Michelle A. Fravel United States 12 63 0.5× 34 0.6× 51 0.9× 41 1.0× 55 1.6× 35 427
R Palencia Germany 7 83 0.6× 51 0.8× 183 3.3× 45 1.1× 53 1.6× 25 386
Sharmini Selvarajah Malaysia 10 152 1.2× 75 1.3× 88 1.6× 95 2.3× 14 0.4× 22 405
Deborah S. Minor United States 11 99 0.8× 31 0.5× 40 0.7× 44 1.1× 15 0.4× 16 256

Countries citing papers authored by Javier Garjón

Since Specialization
Citations

This map shows the geographic impact of Javier Garjón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Garjón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Garjón more than expected).

Fields of papers citing papers by Javier Garjón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Garjón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Garjón. The network helps show where Javier Garjón may publish in the future.

Co-authorship network of co-authors of Javier Garjón

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Garjón. A scholar is included among the top collaborators of Javier Garjón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Garjón. Javier Garjón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garjón, Javier, et al.. (2023). Nirmatrelvir/ritonavir drug-drug interactions in primary care outpatients. SHILAP Revista de lepidopterología. 46(3).
2.
Gil-Setas, Alberto, et al.. (2023). Impact of COVID-19 Pandemic in Antibiotic Consumption in Navarre (Spain): An Interrupted Time Series Analysis. Antibiotics. 12(2). 318–318. 6 indexed citations
3.
4.
Garjón, Javier, et al.. (2022). Gabapentinoides en indicaciones no autorizadas en la ficha técnica: ¿es necesaria una estrategia de desprescripción?. Gaceta Sanitaria. 37. 102283–102283. 1 indexed citations
5.
Garjón, Javier, et al.. (2021). Association between benzodiazepine use and development of dementia. Medicina Clínica (English Edition). 156(3). 107–111. 6 indexed citations
6.
Garcı́a, Eulogio, et al.. (2020). Percutaneous closure of an atrial septal defect in a patient with Ebstein anomaly and right-to-left shunt. Revista Portuguesa de Cardiologia. 39(8). 475.e1–475.e3. 1 indexed citations
7.
Garjón, Javier, et al.. (2020). Association between benzodiazepine use and development of dementia. Medicina Clínica. 156(3). 107–111. 16 indexed citations
8.
Garjón, Javier, et al.. (2017). Implementación y evaluación de un programa de estimulación temprana en preescolares rurales. 34(3). 184–203. 1 indexed citations
9.
Saiz, Luis Carlos, et al.. (2017). Validation and incidence of community-acquired pneumonia in patients with type 2 diabetes in the BIFAP database. Epidemiology and Infection. 145(14). 3056–3064. 5 indexed citations
10.
11.
Garjón, Javier, et al.. (2017). First-line combination therapy versus first-line monotherapy for primary hypertension. Cochrane Database of Systematic Reviews. 1. CD010316–CD010316. 24 indexed citations
12.
Garjón, Javier, et al.. (2014). El docente y el uso de la mediación en los procesos de enseñanza y aprendizaje. 38(83). 155–180. 11 indexed citations
13.
Garjón, Javier, et al.. (2013). Caracterización litogeoquímica del granito La Chinchilla y su relación con el uranio, siella de Velasco, provincia de La Rioja. Revista de la Asociación Geológica Argentina. 70(3). 341–350. 2 indexed citations
14.
Garjón, Javier, et al.. (2012). Adoption of new drugs by physicians: a survival analysis. BMC Health Services Research. 12(1). 56–56. 38 indexed citations
15.
Garjón, Javier, et al.. (2008). Indicadores de calidad de prescripción seleccionados mediante una técnica de consenso. Anales de Pediatría. 69(4). 329–334. 1 indexed citations
16.
Garjón, Javier, et al.. (2007). Velocidad de incorporación de nuevos medicamentos en la práctica clínica. Dialnet (Universidad de la Rioja). 5(4). 118–123. 2 indexed citations
17.
Garjón, Javier, et al.. (2006). Selección de indicadores de calidad de prescripción en atención primaria mediante un grupo de consenso. Atención Primaria. 38(1). 39–44. 6 indexed citations
18.
Garjón, Javier, et al.. (2002). ¿Está justificada la vacunación contra el neumococo en mayores de 65 años?. Atención Primaria. 29(7). 433–437. 4 indexed citations
19.
20.
Martı́n-Alonso, José M., Rosa Casais, M. Soledad Marín, et al.. (2000). Identification and partial characterisation of a Fasciola hepatica gene potentially useful for immunodiagnosis.. Annales de médecine vétérinaire. 144(3). 165–171. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luis Carlos Saiz Breakdown of academic impact, for papers by Seyed Mehrdad Hamrahian Breakdown of academic impact, for papers by Engi Algharably Breakdown of academic impact, for papers by Xindong Qin Breakdown of academic impact, for papers by Eric Dietrich Breakdown of academic impact, for papers by David K Cundiff Breakdown of academic impact, for papers by Michelle A. Fravel Breakdown of academic impact, for papers by R Palencia Breakdown of academic impact, for papers by Sharmini Selvarajah Breakdown of academic impact, for papers by Deborah S. Minor
Rankless by CCL
2026